Mint Tower Capital Management’s Gilead Sciences GILD Stock Holding History

Mint Tower Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,004	Closed	-$430K	–	317
2022 Q4	$430K	Buy	+5,004	New	+$396K	0.04%	246
2022 Q2	–	Sell	-298	Closed	-$18.4K	–	431
2022 Q1	$18K	Buy	+298	New	+$19K	﹤0.01%	315
2020 Q1	–	Sell	-33,650	Closed	-$2.19M	–	251
2019 Q4	$2.19M	Buy	33,650 +25,751	+326%	+$1.68M	0.29%	99
2019 Q3	$501K	Buy	+7,899	New	+$516K	0.07%	135
2019 Q1	–	Sell	-3,251	Closed	-$216K	–	204
2018 Q4	$203K	Buy	+3,251	New	+$227K	0.03%	150
2018 Q3	–	Sell	-3,968	Closed	-$300K	–	229
2018 Q2	$281K	Buy	+3,968	New	+$280K	0.04%	173
2018 Q1	–	Sell	-3,470	Closed	-$276K	–	159
2017 Q4	$249K	Buy	+3,470	New	+$264K	0.04%	116

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mint Tower Capital Management's GILD Position: Q1 2023 in Review

Mint Tower Capital Management sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 5,004 shares — an estimated $430K sold.

Mint Tower Capital Management first reported a position in GILD in Q4 2017 and held it in 7 quarters. The position peaked at $2.19M in Q4 2019. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

Mint Tower Capital Management reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
Mint Tower Capital Management sold 5,004 Gilead Sciences shares in Q1 2023, an estimated $430K.
Mint Tower Capital Management first reported a position in Gilead Sciences in Q4 2017 and held it in 7 quarters.
Mint Tower Capital Management's Gilead Sciences position peaked at $2.19M in Q4 2019.
1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Mint Tower Capital Management's 13F filing for Q1 2023, filed 9 May 2023.